🔗 Permalink

Inventor profile of:

Luigi MORO

City:

Cairate

Country:

Italy

Published Applications:

Last publication date:

2023-04-06

Top Assignees for applications by Luigi MORO

The entities that hold a legal rights for patent applications filed by inventor MORO Luigi:

Cassiopea S.P.A. 6 Lainate (MI), Italy
Cassiopea S.P.A. 5 Lainate, Italy
COSMO TECHNOLOGIES LTD. 4 Dublin, Ireland
COSMO S.P.A. 2 Lainate, Italy
COSMO TECHNOLOGIES INC. 2 Dublin, Ireland
COSMO SPA, 1 Lainate (Milano), Italy
COSMO TECHNOLOGIES LIMITED 1 Dublin, Ireland
COSMO BIO-TECHNOLOGIES SRL 1 Lainate, Italy
Cosmo S.p.A. 1 Lainate (Milan), Italy
Cosmo Dermatos Srl 1 Lainate (MI), Italy

Recent patent applications by MORO Luigi

Luigi MORO from Cairate, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-04-06

US20230104965A1

Human necessities

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

#2 | 2022-09-08

US20220280531A1

Human necessities

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#3 | 2020-08-27

US20200268909A1

Human necessities

SOLID COMPOSITION FOR THE ORAL ADMINISTRATION OF DYES AND DIAGNOSTIC USE THEREOF

#4 | 2020-05-21

US20200155572A1

Human necessities

Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#5 | 2019-03-21

US20190083511A1

Human necessities

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#6 | 2018-08-02

US20180214580A1

Human necessities

SOLID COMPOSITION FOR THE ORAL ADMINISTRATION OF DYES AND DIAGNOSTIC USE THEREOF

#7 | 2016-11-17

US20160331848A1

Human necessities

Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum

#8 | 2016-11-10

US20160326210A1

Chemistry; metallurgy

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#9 | 2016-11-10

US20160324873A1

Human necessities

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#10 | 2016-09-15

US20160263127A1

Human necessities

17alpha, 21-dihydroxypregnene esters as antiandrogenic agents

#11 | 2016-06-30

US20160184460A1

Human necessities

Solid composition for the oral administration of dyes and diagnostic use thereof

#12 | 2016-02-25

US20160051566A1

Human necessities

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#13 | 2014-06-26

US20140179654A1

Chemistry; metallurgy

Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#14 | 2014-06-05

US20140154306A1

Chemistry; metallurgy

17alfa, 21-dihydroxypregnene esters as antiandrogenic agents

#15 | 2013-11-07

US20130295013A1

Human necessities

Solid composition for the oral administration of dyes and diagnostic use thereof

#16 | 2013-10-31

US20130287690A1

Human necessities

Solid composition for the oral administration of dyes and diagnostic use thereof

#17 | 2013-03-07

US20130058867A1

Human necessities

Solid composition for the oral administration of dyes and diagnostic use thereof

#18 | 2009-10-22

US20090264396A1

Human necessities

17α, 21-dihydroxypregnene esters as antiandrogenic agents

#19 | 2009-01-22

US20090023696A1

Human necessities

USE OF C3-C10 17ALFA-ESTERS OF 9,11-DEHYDROCORTEXOLONE AS ANTI-GONADOTROPHIC AGENTS

#20 | 2005-02-03

US20050026889A1

Human necessities

17Afla,21-dihydroxypregnene esters as antiandrogenic agents

InventorID:

126699 ⎘